Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
Oculis’s most advanced product candidate, OCS-01, is currently in Phase 3 development and aims to be the first eye drop
Tag: eye drops
Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
The recently published patent application relates to ophthalmic compositions containing solid complexes of active pharmaceutical ingredient such as dexamethasone and
Aqueous eye drop formulations: Cyclodextrins as enabling excipients
Cyclodextrins are enabling pharmaceutical excipients that solubilize and stabilize drugs in aqueous formulations. Cyclodextrins possess very favorable pharmacokinetic and toxicological
Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study
Ophthalmic tacrolimus compounded formulations are usually made from the commercial intravenous presentation, which contains ethanol as a solubilizer due to
An unprecedented example for sole cyclodextrins as API: an ophthalmic composition with hydroxypropyl betadex, alone
A paradigm shift in cyclodextrin technology started with the design, development and marketing of Sugammadex®/Bridion®, and followed by designation of
Cyclodextrin scientists in the finals for European Inventor Award 2023
Inventors, who made a significant contribution to innovation, economy and society in Europe have been awarded since 2006 by the
Cyclodextrin-enabled nepafenac eye drops with improved absorption
Nepafenac is a highly effective NSAID used for treating postoperative ocular inflammation and pain after cataract surgery and its advantage
Natamycin/HPBCD eye drops for the treatment of fungal keratitis
Fungal keratitis (FK) is a corneal mycotic infection that can lead to vision loss. Furthermore, the severity of FK is
Voriconazole Eye Drops with SBECD and PVA
Fungal keratitis is one of the leading causes of blindness in developing countries. The infections are associated with ocular trauma
Oil-free eye drops containing Cyclosporine A/SBECD/PVA supramolecular complex
According to the global mapping of dry eye disease (DED), nearly 5 to 50 % of people suffer from DED,